AIF-1 stimulates undesirable formation of new cells after a vascular injury, and IRT-1 has the opposite effect. It is the latter, IRT-1, that Maria Gomez wants to use to stop a dangerous development in the artery, together with researchers at Lund University Diabetes Centre in Sweden and Temple University in the USA. They have already had success in animal experiments.
“After an arterial injury, the inner layer of cells in the artery begins to regrow. In the long term, this usually causes more harm than good”, says Maria Gomez.
A common cause of arterial injuries is the clearing of blocked arteries often performed on patients who have had a heart attack.
“Initially the artery is opened up, but after a while new cell formation increases the risk of further heart attacks.”In animal experiments, the research groups have demonstrated the opposite effects of the two proteins. The carotid artery of rats was damaged with balloon dilation, simulating the procedure carried out on heart attack patients.
After two weeks, there was noticeably less new cell formation in the arteries that had more of the protein IRT-1. With AIF-1, the opposite effect was observed.
“The interesting thing is that both proteins are formed from the same gene and we have now found a mechanism to control the balance in the formation of the two. Using a new drug we can thus increase the amount of the ‘good’ protein, IRT-1. It is not an approved drug, but it has been tested on mice and appears to be tolerated well”, says Maria Gomez.
The researchers have also analysed over 150 fatty deposits (‘plaques’) removed from the carotid arteries of patients.
“We saw that the dangerous plaques – those that are unstable, easily rupture, are more inflamed and more often produce symptoms – contain more AIF-1. Those with a higher proportion of the protein IRT-1 are less dangerous”, observes Lisa Berglund, co-author of the published study.
Diabetes patients develop more plaques, and more often dangerous ones, than non-diabetics. Diabetics have a significantly higher risk of suffering a heart attack.
The regrowth of cells in the arteries also leads to negative changes in blood flow. It may even be the case that AIF-1 is involved in the actual formation of plaques in the arteries.
Heart attacks are the most common cause of death in Sweden and many patients have repeated attacks, which are treated by clearing constrictions in the arteries of the heart using various methods.
“If we could reduce the risk of repeat attacks, this would represent very significant progress”, says Maria Gomez.
The study has been published in the scientific journal Cardiovascular Research:
"NFAT regulates the expression of AIF-1 and IRT-1: Yin and yang splice variants of neointima formation and atherosclerosis"For more information, please contact: Maria.Gomez@med.lu.se
Megan Grindlay | idw
Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery
20.01.2017 | GSI Helmholtzzentrum für Schwerionenforschung GmbH
Seeking structure with metagenome sequences
20.01.2017 | DOE/Joint Genome Institute
An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...
Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales
Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...
Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.
As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...
19.01.2017 | Event News
10.01.2017 | Event News
09.01.2017 | Event News
20.01.2017 | Awards Funding
20.01.2017 | Materials Sciences
20.01.2017 | Life Sciences